NASDAQ · Financial Statements

Nephros, Inc. (NEPH) Financial Statements

$3.53 NASDAQ: NEPH Market Cap $38.32M

Nephros, Inc. most recently reported annual revenue of $19.0M, net profit of $1.0M, revenue has compounded at 16.1% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$10.0M$14.0M$14.0M$19.0M
Operating Profit$-3.0M$-4.0M$-2.0M$0$1.0M
Net Profit$-4.0M$-7.0M$-2.0M$0$1.0M
EPS$-0.41$-0.72$-0.15$0.01$0.11
Op Margin-31.8%-43.5%-11.2%0.0%6.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$18.0M$11.0M$12.0M$11.0M$14.0M
Total Liabilities$3.0M$2.0M$4.0M$3.0M$3.0M
Cash$7.0M$4.0M$4.0M$4.0M$5.0M
Borrowings$1.0M$1.0M$2.0M$1.0M$1.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-3.0M$1.0M$0$2.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-1.0M$-3.0M$1.0M$-1.0M$2.0M
Free Cash Flow$-1.0M$-3.0M$1.0M$-1.0M$2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.99
EV / EBITDA19.82
FCF Yield-1.66%
Quick Ratio2.71
Interest Coverage1642.00
Return 1Y3.68%
Return 3Y161.43%
Return 5Y-59.24%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
NEPH Overview NEPH Dividend Run Stock Screener